Vanda Pharmaceuticals
VNDA
VNDA
189 hedge funds and large institutions have $389M invested in Vanda Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 76 increasing their positions, 52 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
16% less call options, than puts
Call options by funds: $354K | Put options by funds: $420K
29% less capital invested
Capital invested by funds: $544M → $389M (-$155M)
Holders
189
Holding in Top 10
–
Calls
$354K
Puts
$420K
Top Buyers
| 1 | +$12.1M | |
| 2 | +$3.92M | |
| 3 | +$3.4M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$2.41M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.29M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$9.81M | |
| 3 | -$7.97M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$3.74M |
| 5 |
Renaissance Technologies
New York
|
-$3M |